This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Becker, Michael
| Item Type | Name |
|
Concept
|
Thiazoles
|
|
Academic Article
|
Update on emerging urate-lowering therapies.
|
|
Academic Article
|
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
|
|
Academic Article
|
Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers.
|
|
Academic Article
|
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
|
|
Academic Article
|
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
|
|
Academic Article
|
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
|
|
Academic Article
|
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
|
|
Academic Article
|
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
|
|
Academic Article
|
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
|
|
Academic Article
|
Treating hyperuricemia of gout: safety and efficacy of febuxostat and allopurinol in older versus younger subjects.
|
|
Academic Article
|
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy.
|
|
Academic Article
|
Diabetes and gout: efficacy and safety of febuxostat and allopurinol.
|
|
Academic Article
|
Long-term management of gout: nonpharmacologic and pharmacologic therapies.
|
|
Academic Article
|
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.
|
|
Academic Article
|
Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial.
|